In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Almirall completes €102mm flotation on Spanish market

Executive Summary

Laboratorios Almirall SA (mainly respiratory/pulmonary, CNS, and immune system disorder therapeutics) completed an 8mm share IPO on the Spanish Stock Exchange at a price of €14 apiece, netting about €102mm ($137mm) and valuing the company at about €2.3bn. The oversubscribed offering took place in three tranches and selling shareholders offered an additional 37.3mm shares
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies